Line of therapy adjustment in a patient with advanced triple-negative breast cancer (TNBC) by using personalized ctDNA test for treatment response monitoring. (April 2021) - Azzi, G.; Krinshpun, S.; Tin, A.; Malashevich, A.; Malhotra, M.; Billings, P.; Rodriguez, A.; Aleshin, A.